Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Novartis”
- Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
MSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers
United States, Belgium, China, France, Germany +10 more
- Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'IvoireNot Yet Recruiting
Sponsor: Swiss Tropical & Public Health Institute
Sickle Cell Disease (SCD)
Côte d’Ivoire
Sponsor: Novartis Pharmaceuticals
Kidney Transplantation
United States, Argentina, Australia, Belgium, Brazil +15 more
Sponsor: Novartis Pharmaceuticals
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
China
Sponsor: Novartis Pharmaceuticals
Primary Immune Thrombocytopenia · Sjögren's Syndrome
Sponsor: Hackensack Meridian Health
Prostate Adenocarcinoma
United States
Sponsor: Novartis Pharmaceuticals
Metastatic Prostate Cancer
- Real World Adherence of PCSK9 Targeted TherapyNot Yet Recruiting
Sponsor: Novartis Pharmaceuticals
Dyslipidemia, Hypercholesterolemia
Sponsor: Novartis Pharmaceuticals
Muscular Atrophy, Spinal
Czechia
Sponsor: Novartis Pharmaceuticals
Prostate Cancer
United States
- Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion DependenceActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Myelodysplastic Syndromes
Japan
- Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
KRAS G12C Mutant Solid Tumors · Carcinoma, Non-Small-Cell Lung · Carcinoma, Colorectal · Cancer of Lung
United States, Australia, Belgium, Canada, China +11 more
- IgA Nephropathy Insights From Treatment Experience Among Patients Receiving Iptacopan and/or Atrasentan Using Primary Data CollectionNot Yet Recruiting
Sponsor: Novartis Pharmaceuticals
IgA Nephropathy
Sponsor: Novartis Pharmaceuticals
Chronic Myelogenous Leukemia
Argentina, Austria, Brazil, Canada, France +11 more
- Clinical Trial of Alpelisb and Tucatinib in Patients With PIK3CA-Mutant HER2+ Metastatic Breast Cancer.Active Not Recruiting
Sponsor: Criterium, Inc.
HER2-positive Metastatic Breast Cancer
United States
- Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in FranceActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Breast Cancer
France
- Managed Access Programs for INC280, CapmatinibNo Longer Available
Sponsor: Novartis Pharmaceuticals
Non-Small Cell Lung Cancer
Sponsor: Novartis Pharmaceuticals
Allergic Rhinitis
Sponsor: University Hospital, Strasbourg, France
Haemodialyzed, Type 2 Diabetes
France
Sponsor: Centre Oscar Lambret
Melanoma
France
Sponsor: Jonsson Comprehensive Cancer Center
Castration-Resistant Prostate Carcinoma · Stage IVB Prostate Cancer AJCC v8
United States
Sponsor: UroTrials Company (GmbH)
Prostate Cancer · Biochemical Recurrence of Malignant Neoplasm of Prostate · Non-metastatic Castration-resistant Prostate Cancer · Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Germany
- Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic MelanomaActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Melanoma
United States, Argentina, Australia, Belgium, France +7 more
- An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With RemibrutinibActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Chronic Spontaneous Urticaria
United States, Argentina, Australia, Brazil, Bulgaria +25 more
- Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast CancerActive Not Recruiting
Sponsor: Qamar Khan
Breast Cancer
United States